Abstract
Diabetes is one of the most important risk factor for stroke and cardiovascular disease (CVD), especially in young patients. The control of classical vascular risk factors failed in terms of prevention of stroke in patients with diabetes. In addiction, in these patients the glycemic control showed a benefit on microvascular disease but lacked an established benefit in macrovascular disease. Therefore, implementations of effective stroke prevention strategies appear necessary in patients with diabetes. Ultrasound surrogate or intermediate markers of carotid atherosclerosis include carotid intima-media thickness (cIMT), carotid plaque (CP), and carotid stiffness (STIFF) have been demonstrated to increase in patients with diabetes and to be able to predict risk for stroke. In this editorial we discuss the opportunity to prevent the onset of vascular disease in their “preclinical or subclinical” stage in patients with higher risk for stroke such as diabetic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, Sacco RL, Elkind MS (2012) Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke 43:1212–1217
Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570–2581
Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL (2008a) Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care 31:1132–1137
Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC (2008b) Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39:30–35
de Kreutzenberg SV, Coracina A, Volpi A, Fadini GP, Frigo AC, Guarneri G, Tiengo A, Avogaro A (2011) Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. Nutr Metab Cardiovasc Dis 21:286–293
Della-Morte D, Guadagni F, Palmirotta R, Testa G, Caso V, Paciaroni M, Abete P, Rengo F, Ferroni P, Sacco RL, Rundek T (2012) Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics 13:595–613
Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O’Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Witteman JC, Moons KG, Bots ML (2012) Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 308:796–803
El-Atat F, Rundek T, Sowers JR, McFarlane SI (2005) Stroke prevention in diabetic and other high cardiovascular risk patients. Curr Diab Rep 5:200–207
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421–1428
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497
Ferroni P, Della-Morte D, Pileggi A, Valente MG, Martini F, La Farina F, Palmirotta R, Meneghini LF, Rundek T, Ricordi C, Guadagni F (2012a) Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assay. Cardiovasc Drugs Ther 26:301–309
Ferroni P, Della-Morte D, Pileggi A, Riondino S, Rundek T, Ricordi C, Guadagni F (2012b) Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus. Curr Vasc Pharmacol 10:6
Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD, Hoorn Study (2003) Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107:2089–2095
Kadoglou NP, Avgerinos ED, Liapis CD (2010) An update on markers of carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med 4:601–609
Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, Miller R, Ewing I, Moomaw CJ, Szaflarski JP, Gebel J, Shukla R, Broderick JP (2005) Epidemiology of ischemic stroke in patients with diabetes. The greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28:355–359
Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O’Leary D, Psaty B, Robbins J (1994) Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 139:1164–1179
Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O’Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823–829
Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MS, Sacco RL, Rundek T (2012) Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 43:1755–1760
Mathiesen EB, Johnsen SH, Wilsgaard T, Bønaa KH, Løchen ML, Njølstad I (2011) Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study. Stroke 42:972–978
McFarlane SI, Rundek T, Nicasio J, Deshmukh M, Sowers JR (2006) The DREAM trial and the prospect of diabetes prevention. Curr Diab Rep 6:205–206
Mukamal KJ, Kizer JR, Djoussé L, Ix JH, Zieman S, Siscovick DS, Sibley CT, Tracy RP, Arnold AM (2012) Prediction and classification of cardiovascular disease risk in older adults with diabetes. Diabetologia
Norris JM, Rich SS (2012) Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome. Arterioscler Thromb Vasc Biol 32:2091–2096
Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB Sr (2011) Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365:213–221
Reyes-Soffer G, Ngai CI, Lovato L, Karmally W, Ramakrishnan R, Holleran S, Ginsberg HN (2012) Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial. Diabetes Care
Riddle MC, Karl DM (2012) Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials. Diabetes Care 35:2100–2107
Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL (2008) Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 70:1200–1207
Simon A, Megnien JL, Chironi G (2010) The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 30:182–185
Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Daffertshofer M, Cimboneriu A, Zis V, Lekakis J, Zakopoulos N, Mavrikakis M (2006) Common carotid arterial stiffness and the risk of ischaemic stroke. Eur J Neurol 13:475–481
Acknowledgments
This work was supported by the National Institute of Neurological Disorders and Stroke grant: K24 NS062737 (Dr. Rundek).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Della-Morte, D., Ricordi, C., Guadagni, F. et al. Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes. Metab Brain Dis 28, 337–339 (2013). https://doi.org/10.1007/s11011-013-9385-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-013-9385-3